SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
4.170
-0.100 (-2.34%)
Feb 20, 2026, 4:00 PM EST - Market closed

SBC Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22
42857159154
Market Cap Growth
-18.69%866.28%-61.53%-
Enterprise Value
328463--
Last Close Price
4.175.5610.7710.20
PE Ratio
9.9212.261.5024.34
PS Ratio
2.402.780.310.88
PB Ratio
1.722.930.411.43
P/TBV Ratio
1.953.020.501.63
P/FCF Ratio
-33.261.44-
P/OCF Ratio
-27.761.17-
EV/Sales Ratio
1.842.25--
EV/EBITDA Ratio
4.255.19--
EV/EBIT Ratio
4.415.42--
EV/FCF Ratio
-26.94--
Debt / Equity Ratio
0.110.060.160.15
Debt / EBITDA Ratio
0.350.130.260.53
Debt / FCF Ratio
-0.710.56-
Net Debt / Equity Ratio
-0.40-0.58-0.56-0.35
Net Debt / EBITDA Ratio
-1.28-1.26-0.97-1.43
Net Debt / FCF Ratio
2.71-6.57-1.951.50
Asset Turnover
0.580.780.80-
Inventory Turnover
25.2421.5325.33-
Quick Ratio
4.752.831.680.96
Current Ratio
5.103.011.801.12
Return on Equity (ROE)
19.10%27.56%30.64%-
Return on Assets (ROA)
15.05%20.33%18.24%-
Return on Invested Capital (ROIC)
36.17%74.41%55.27%6.79%
Return on Capital Employed (ROCE)
26.90%41.70%42.50%16.40%
Earnings Yield
10.13%8.16%66.59%4.11%
FCF Yield
-8.56%3.01%69.59%-16.26%
Buyback Yield / Dilution
-9.13%-2.51%-1084.96%-
Updated Nov 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q